These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 10566152)

  • 1. Mucosal immunity and tolerance: relevance to vaccine development.
    Czerkinsky C; Anjuere F; McGhee JR; George-Chandy A; Holmgren J; Kieny MP; Fujiyashi K; Mestecky JF; Pierrefite-Carle V; Rask C; Sun JB
    Immunol Rev; 1999 Aug; 170(1):197-222. PubMed ID: 10566152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for mucosal vaccine development.
    Boyaka PN; Marinaro M; Vancott JL; Takahashi I; Fujihashi K; Yamamoto M; van Ginkel FW; Jackson RJ; Kiyono H; McGhee JR
    Am J Trop Med Hyg; 1999 Apr; 60(4 Suppl):35-45. PubMed ID: 10344675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives in vaccine development: mucosal immunity to infections.
    McGhee JR; Kiyono H
    Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel vaccine development strategies for inducing mucosal immunity.
    Fujkuyama Y; Tokuhara D; Kataoka K; Gilbert RS; McGhee JR; Yuki Y; Kiyono H; Fujihashi K
    Expert Rev Vaccines; 2012 Mar; 11(3):367-79. PubMed ID: 22380827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic manipulation of the immune system: enhancement of innate and adaptive mucosal immunity.
    Boyaka PN; Tafaro A; Fischer R; Fujihashi K; Jirillo E; McGhee JR
    Curr Pharm Des; 2003; 9(24):1965-72. PubMed ID: 12871182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for mucosal immunity to combat emerging infectious diseases.
    van Ginkel FW; Nguyen HH; McGhee JR
    Emerg Infect Dis; 2000; 6(2):123-32. PubMed ID: 10756145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in mucosal vaccines and adjuvants.
    Eriksson K; Holmgren J
    Curr Opin Immunol; 2002 Oct; 14(5):666-72. PubMed ID: 12183170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 12 and innate molecules for enhanced mucosal immunity.
    Boyaka PN; Lillard JW; McGhee J
    Immunol Res; 1999; 20(3):207-17. PubMed ID: 10741861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
    Boyaka PN
    J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
    Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR
    J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucosal immunity and vaccine development].
    Anjuère F; Czerkinsky C
    Med Sci (Paris); 2007 Apr; 23(4):371-8. PubMed ID: 17433226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges.
    Holmgren J; Czerkinsky C; Eriksson K; Mharandi A
    Vaccine; 2003 Jun; 21 Suppl 2():S89-95. PubMed ID: 12763689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immune network in the gut for the control of infectious diseases.
    Iijima H; Takahashi I; Kiyono H
    Rev Med Virol; 2001; 11(2):117-33. PubMed ID: 11262530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mucosal IgA response, but no systemic antibody response, is evoked by intranasal immunisation of dogs with Echinococcus granulosus surface antigens iscoms.
    Carol H; Nieto A
    Vet Immunol Immunopathol; 1998 Sep; 65(1):29-41. PubMed ID: 9802574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The common mucosal immune system and current strategies for induction of immune responses in external secretions.
    Mestecky J
    J Clin Immunol; 1987 Jul; 7(4):265-76. PubMed ID: 3301884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts.
    Klavinskis LS; Barnfield C; Gao L; Parker S
    J Immunol; 1999 Jan; 162(1):254-62. PubMed ID: 9886393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses.
    Sun X; Zhang H; Xu S; Shi L; Dong J; Gao D; Chen Y; Feng H
    Virol J; 2017 Aug; 14(1):163. PubMed ID: 28830557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of immunomodulators and the mucosal immune system.
    Revillard JP; Cozon G; Czerkinsky C
    Dev Biol Stand; 1992; 77():31-7. PubMed ID: 1426671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens.
    McGhee JR; Mestecky J
    Infect Dis Clin North Am; 1990 Jun; 4(2):315-41. PubMed ID: 2189002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
    Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
    Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.